Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c320 |
|---|---|
| Identifier | NCT03829475 |
| Trial Title | ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Clostridium Difficile Infection |
| Interventions | DRUG: Bezlotoxumab|DRUG: Placebo|DRUG: Fecal Microbiota Transplantation |
Participant Information
| Sponsor | Brigham and Women's Hospital |
|---|---|
| City | Boston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2020-01-01 |
|---|---|
| Primary Completion Date | 2023-08-03 |
| Completion Date | 2025-06-01 |